Prognostic significance of dysadherin expression in patients with non-small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 130, Issue 3, 2005, Pages 740-745

  Tamura, Masaya ^a   Ohta, Yasuhiko ^a   Tsunezuka, Yoshio ^a   Matsumoto, Isao ^a   Kawakami, Kazuyuki ^a   Oda, Makoto ^a   Watanabe, Go ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; DYSADHERIN; MEMBRANE PROTEIN; PEROXIDASE; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 24644513485     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.12.051     Document Type: Article

References (12)

1. T. Hirata, T. Fukuse, H. Naiki, H. Wada Expression of E-cadherin and lymph node metastasis in resected non-small cell lung caner Clin Lung Cancer 3 2001 134 140
2. Y. Ino, M. Gotoh, M. Sakamoto, K. Tsukagishi, S. Hirohashi Dysadherin, a cancer-associated cell membrane glycoprotein, down regulates E-cadherin and promotes metastasis Proc Natl Acad Sci U S A 99 2002 365 370
3. S. Aoki, T. Shimamura, T. Shibata Prognostic significance of dysadherin expression in advanced colorectal carcinoma Br J Cancer 88 2003 726 732
4. H. Sato, Y. Ino, A. Miura Dysadherin Expression and clinical significance in thyroid carcinoma J Clin Endocrinol Metab 88 2003 4407 4412
5. T. Shimamura, M. Sakamoto, Y. Ino Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness relationship to E-cadherin expression J Clin Oncol 15 2003 659 667
6. S. Kase, K. Sugio, K. Yamazaki, T. Okamoto, T. Yano, K. Sugimachi Expression of E-cadherin and beta-catenine in human non-small cell lung cancer and the clinical significance Clin Cancer Res 6 2000 4789 4796
7. J. Gofuku, H. Shiozaki, T. Tsujinaka Expression of E-cadherin and alpha-catenine in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis Am J Clin Pathol 111 1999 29 37
8. R. Umbas, W.B. Isaacs, P.P. Bringuiter Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer Int J Cancer 74 1997 374 377
9. A. Katagiri, R. Watanabe, Y. Tomita E-cadherin expression in renal cell cancer and its significance in metastasis and survival Br J Cancer 71 1995 376 379
10. P.K. Lipponen, M.J. Eskelinen Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer J Cancer Res Clin Oncol 121 1995 303 308
11. Y. Yonemura, N. Nojima, M. Kaji E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma Cancer 76 1995 941 953
12. S. Tamura, H. Shiozaki, M. Miyata Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus Br J Surg 83 1996 1608 1614